Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Tuberculosis, Drug-Resistant

glucose, (beta-d)-isomer has been researched along with Tuberculosis, Drug-Resistant in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Ashman, J; Bekker, LG; Bilek, N; Coler, RN; Day, TA; Diacon, A; Du Plessis, N; Fiore-Gartland, A; Frevol, A; Geldenhuys, H; Hatherill, M; Lindestam Arlehamn, C; Loxton, AG; Luabeya, AKK; Mabwe, S; Penn-Nicholson, A; Reed, SG; Reid, TD; Rolf, TA; Sagawa, ZK; Scriba, TJ; Sette, A; Shenje, J; Tameris, M; Toefy, A; Vergara, J; Walzl, G	1
Chen, H; Deng, KZ; Deng, MZ; Luo, YM; Xiong, Y; Zhou, B	1
Aderogba, MA; Finnie, JF; Madikizela, B; Van Staden, J	1

Trials

1 trial(s) available for glucose, (beta-d)-isomer and Tuberculosis, Drug-Resistant

Article	Year
Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial. The Lancet. Respiratory medicine, 2021, Volume: 9, Issue:4 Topics: Adjuvants, Immunologic; Adolescent; Adult; Antibodies, Bacterial; Antitubercular Agents; Dose-Response Relationship, Immunologic; Double-Blind Method; Female; Glucosides; Humans; Immunogenicity, Vaccine; Lipid A; Male; Middle Aged; Mycobacterium tuberculosis; Recurrence; Secondary Prevention; Tuberculosis Vaccines; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult	2021

Article

Year

Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial.

The Lancet. Respiratory medicine, 2021, Volume: 9, Issue:4

Topics: Adjuvants, Immunologic; Adolescent; Adult; Antibodies, Bacterial; Antitubercular Agents; Dose-Response Relationship, Immunologic; Double-Blind Method; Female; Glucosides; Humans; Immunogenicity, Vaccine; Lipid A; Male; Middle Aged; Mycobacterium tuberculosis; Recurrence; Secondary Prevention; Tuberculosis Vaccines; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult

2021

Other Studies

2 other study(ies) available for glucose, (beta-d)-isomer and Tuberculosis, Drug-Resistant

Article	Year
[Constituents from Ranunculus ternatus and Their Inhibitory Effects on Multidrug-Resistant Tuberculosis]. Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2016, Volume: 39, Issue:4 Topics: Drugs, Chinese Herbal; Glucosides; Magnetic Resonance Spectroscopy; Ranunculus; Tuberculosis, Multidrug-Resistant	2016
Isolation and characterization of antimicrobial compounds from Terminalia phanerophlebia Engl. & Diels leaf extracts. Journal of ethnopharmacology, 2014, Oct-28, Volume: 156 Topics: Anti-Infective Agents; Glucosides; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plant Extracts; Plant Leaves; Staphylococcus aureus; Terminalia; Tuberculosis, Multidrug-Resistant	2014